• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Analysis of iosulamide in plasma and urine: application to intravenous pharmacokinetics in rhesus monkey.

作者信息

Park G B, Biddlecome C E, Rowe E A, Kullberg M P, Edelson J

出版信息

Drug Metab Dispos. 1981 Jan-Feb;9(1):43-7.

PMID:6111430
Abstract

A sensitive, specific, high-performance liquid-chromatographic method for the determination of iosulamide in plasma and urine is described. The method was used to determine pharmacokinetic parameters of iosulamide after intravenous administration to rhesus monkeys. The mean (+/- SE) distribution and disposition half-lives were 0.19 (+/- 0.03) and 1.5 (+/- 0.3) hr, respectively. The mean (+/- SE) model-dependent and model-independent volumes of distribution at steady state were 0.41 +/- (0.078) and 0.49 (+/- 0.039) liters/kg, respectively. Total urinary excretion of iosulamide represented a mean (+/- SE) of 12.5 (+/- 0.6)% of the administered dose and was virtually complete in 3 hr. The results of the pharmacokinetic study indicate that iosulamide is rapidly cleared from the body and that renal clearance is a minor route of elimination from the body.

摘要

相似文献

1
Analysis of iosulamide in plasma and urine: application to intravenous pharmacokinetics in rhesus monkey.
Drug Metab Dispos. 1981 Jan-Feb;9(1):43-7.
2
Iosulamide: a new intravenous cholangiocholecystographic medium.碘磺酰胺:一种新型静脉胆管胆囊造影剂。
Invest Radiol. 1980 Nov-Dec;15(6 Suppl):S142-7.
3
Pharmacokinetic disposition of guanabenz in the rhesus monkey.
Drug Metab Dispos. 1981 Nov-Dec;9(6):509-14.
4
The influence of diazepam on the pharmacokinetics of intravenous and epidural bupivacaine in the rhesus monkey.地西泮对恒河猴静脉注射和硬膜外注射布比卡因药代动力学的影响。
Anesth Analg. 1986 Feb;65(2):151-5.
5
Concentration-time effects of quinidine disposition kinetics in rhesus monkeys.
J Pharmacol Exp Ther. 1977 Mar;200(3):459-68.
6
Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.绿草定(3,5,6-三氯-2-吡啶氧基乙酸)在比格犬和恒河猴体内的药代动力学:关于犬相对于大鼠、猴和人类排泄这种有机酸能力降低的研究视角
Toxicol Appl Pharmacol. 1997 Jun;144(2):268-78. doi: 10.1006/taap.1997.8136.
7
Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.人白细胞弹性蛋白酶的口服活性抑制剂。I. L-683,845在大鼠和恒河猴体内的处置情况。
Drug Metab Dispos. 1996 Dec;24(12):1369-77.
8
Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
Drug Metab Dispos. 1993 Sep-Oct;21(5):855-60.
9
Pharmacokinetics of recombinant human interferon-gamma in the rhesus monkey after intravenous, intramuscular, and subcutaneous administration.重组人γ干扰素在恒河猴静脉内、肌肉内和皮下给药后的药代动力学
J Biol Response Mod. 1988 Apr;7(2):115-22.
10
Pharmacokinetics of sodium mercaptoundecahydrododecaborate after intravenous injection in rats.
Drug Metab Dispos. 1995 Dec;23(12):1368-71.